English

Zanubrutinib

Short Description:

API’s Name Indication Innovator Patent Expiry Date(The U.S)
Zanubrutinib MCL/CLL/SLL/WM BeiGene  Apr.2034


Product Detail

Product Tags

Mantle cell lymphoma(MCL)，Chronic Lymphocytic Leukemia(CLL)/Small lymphocytic lymphoma（SLL），Waldenstrom macroglobulinemia（WM）

  • Previous:
  • Next:
    • Write your message here and send it to us

    Products categories